A Game-Changing Idea for Rapid Cancer Screening: Detection of Circulating Tumor DNA on the Surface of Red Blood Cells
ISEF · 2023 Translational Medical Science
Overview
Nowadays, liquid biopsies based on detecting cell-free DNA (cfDNA) by Real-Time PCR have gained momentum in cancer diagnosis owing to their painlessness to patients. However, detecting cancer by this technique is inefficient as the concentration and lifespan of circulating tumor DNA (ctDNA) in plasma are low and short respectively, due to nuclease digestion. This work demonstrated a challenging approach to detect ctDNA on the surface of red blood cells instead of plasma. The concentration of cell surface-bound DNA (csbDNA) was expected to be increased via a DNA binding property of Toll-like receptor (TLR) presenting on red blood cell surfaces. As chicken TLR21 is a homolog to human TLR9, it likely binds ctDNA. This assumption together with the safety issue let us select food-grade chicken blood as a representative model. Cell-free DNA circulation in blood was mimicked by mixing cancer DNA (amplified HER2 gene) from SKBR3 and MDA-MB-231 (triple-negative cell), and blood cells. Real-Time PCR was used to quantitate csbDNA and determine the ratio between the cycle threshold (Ct) of HER2 and EIF5B (internal control) genes, compared to those of the original cells. The ratio between the Ct of both genes from MDA-MB-231 is close to 1:1 and from SKBR3 is approximately 4:1, which matches the ratio from the original cells. This can be concluded that our proposed strategy could enhance the concentration and stability of csbDNA, which in turn boost real-time PCR sensitivity for earlier-stage detection of cancer. The positive outcome of this research is a game-changing idea for rapid cancer screening that potentially prevents millions of cancer deaths worldwide. Keywords: Toll-like receptor (TLR), circulating tumor DNA (ctDNA), Liquid biopsy, HER2, cell surface-bound DNA (csbDNA)
Competition history
- ISEF 2023
Resources
Related projects
ISEF · 2014
Early Cancer Diagnosis and Treatment through the Detection of Circulating Tumor Cells Using Drop-based Microfluidics
ISEF · 2019
Ultrasensitive Detection of Early-Stage Cancer Using ctDNA Sequencing with UMIs
ISEF · 2018
Novel Nanotechnology for the Detection of Circulating Tumor Cells
ISEF · 2018
Urine as an Alternative to Blood for Cancer Liquid Biopsy and Precision Medicine
ISEF · 2021
CarC SPY: Non-Invasive Early Stage Multi-Cancer Detection Using AI-based Electrochemical Biosensor to Detect Circulating Tumor Cells (CTCs)
ISEF · 2017
Development of Novel Method Using RNA Template for Detection of Mutation with Superior Sensitivity
ISEF · 2025
Dethroning the King of Cancers: Pancreatic Cancer Diagnosis From Blood Enabled by a Cocktail of Antibody-Magnetic Nanospheres
ISEF · 2020
A Matter of Life and Breath: Early Lung Cancer Detection via Deep Learning CT Scan Analysis and DNA Methylation/exRNA Sequencing
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair